SCHEMBL19146234

SCHEMBL19146234

CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](NCc2ccccc2)[C@@H](CO)O[C@H]1n1cnc2c(N)ncnc21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 4/20 0.51
▸ ADORA3 P0DMS8 4/20 0.49
▸ SLC29A1 Q99808 2/20 0.49
▸ PI4KA P42356 2/20 0.49
▸ PI4K2B Q8TCG2 2/20 0.49
▸ PI4K2A Q9BTU6 2/20 0.49
▸ PI4KB Q9UBF8 2/20 0.49
▸ DPP4 P27487 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ SLC28A1 O00337 1/20 0.49
▸ MAP3K7 O43318 1/20 0.49
▸ SLC28A2 O43868 1/20 0.49
▸ GAPDH P04406 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ ADORA2A P29274 1/20 0.49
▸ ADORA2B P29275 1/20 0.49
▸ STAT6 P42226 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ DOT1L Q8TEK3 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19927540 0.88 AHCY (0.53) ADORA1DOT1LAHCY
SCHEMBL21565155 0.88 AHCY (0.53) ADORA1DOT1LAHCY
SCHEMBL20637781 0.84 ADORA1 (0.50) ADORA1DOT1LAHCY
SCHEMBL19146315 0.83 HINT1 (0.55) ADORA3ADORA2A
SCHEMBL19145745 0.83 ADORA3 (0.66) ADORA1ADORA3SLC29A1PI4KAPI4K2B
SCHEMBL21859283 0.83 ADORA3 (0.61) ADORA1ADORA3SLC29A1PI4KAPI4K2B
SCHEMBL22220139 0.83 ADORA3 (0.61) ADORA1ADORA3SLC29A1PI4KAPI4K2B
SCHEMBL22220276 0.83 ADORA3 (0.61) ADORA1ADORA3SLC29A1PI4KAPI4K2B
SCHEMBL21859152 0.83 ADORA3 (0.61) ADORA1ADORA3SLC29A1PI4KAPI4K2B
SCHEMBL13773257 0.83 ADORA3 (0.61) ADORA1ADORA3SLC29A1PI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017123669-A1 CYCLIC DINUCLEOTIDES FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY SUCH AS CANCER GLICK GARY (US) 2017-07-20 — — WO disclosed
Send feedback